TigerGene

Valora Therapeutics, based in San Diego, California, is a biotechnology company focused on the development of innovative biological drugs. It specializes in engineering chimeric antibodies, which are designed to harness the body's immune system to fight cancer and other diseases. The company operates at the pre-clinical stage, working to unlock new mechanisms of immune signaling and activity, with the aim of providing transformative therapies to the healthcare industry.

NanoMosaic specializes in developing innovative solutions for early illness detection, prognostic monitoring, and biomarker identification. The company utilizes a unique nanoneedle proteomic platform that facilitates protein detection and quantification on a single chip. This technology enhances the capabilities of the medical and healthcare industry by accelerating the discovery and validation of biomarkers, thereby improving early disease detection and monitoring. Through its advanced proteomic system, NanoMosaic aims to contribute significantly to advancements in medical diagnostics and patient care.